Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Year-over-year gross profit growth rate
Percentile
P10
Near historical low
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -60.79% |
| Q3 2025 | 163.98% |
| Q2 2025 | 24.15% |
| Q1 2025 | -22.85% |
| Q4 2024 | 5.14% |
| Q3 2024 | -7.30% |
| Q2 2024 | 16.13% |
| Q1 2024 | 19.93% |
| Q4 2023 | 43.73% |
| Q3 2023 | 1.62% |
| Q2 2023 | 133.79% |
| Q1 2023 | 87.64% |
| Q4 2022 | -4.53% |
| Q3 2022 | 27.31% |
| Q2 2022 | 23.65% |
| Q1 2022 | -78.06% |
| Q4 2021 | 988.33% |
| Q3 2021 | 782.99% |
| Q2 2021 | 258.12% |
| Q1 2021 | -100.16% |
| Q4 2020 | 38556.35% |
| Q3 2020 | 629.51% |
| Q2 2020 | 14.08% |
| Q1 2020 | 34.22% |
| Q4 2019 | 99.69% |
| Q3 2019 | -10.20% |
| Q2 2019 | -30.47% |
| Q1 2019 | -421612.74% |
| Q4 2018 | 100.03% |
| Q3 2018 | -6.93% |
| Q2 2018 | -56.19% |
| Q1 2018 | -185839.04% |
| Q4 2017 | 100.10% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | 0.00% |
| Q1 2016 | 0.00% |